Clinical Trial Update: Comparison Trial for Chloraprep Versus Aqueous Chlorhexidine (2%) for the Prevention of Catheter-related Bacteremia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Chloraprep to aqueous chlorhexidine for preventing catheter-related bacteremia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Venous Catheter-related Bacteremia
• Sepsis Affecting Skin

Drugs mentioned

• ChloraPrep (chlorhexidine gluconate)
• Chlorhexidine (chlorhexidine)

Snippet

Sponsor: Instituto de Investigacion Sanitaria La Fe | Conditions: Sepsis Affecting Skin, Central Venous Catheter Related Bacteremia | Phase 4 | Status: WITHDRAWN